Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2980-2985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 72-77

Karger

Access to resources Recommend Favorite

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2947-2958

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite

Erlotinib-associated dermatological toxicity

By Mumoli Nicola  

QJM: An International Journal of Medicine, Vol. 106, Iss. 4, 2013-04 ,pp. : 363-364

Oxford University Press

Access to resources Recommend Favorite